Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Sep 12;2012(9):CD009536.
doi: 10.1002/14651858.CD009536.pub2.

Medical treatment for small abdominal aortic aneurysms

Guy Rughani  1 , Lindsay Robertson, Mike Clarke
Affiliations
Meta-Analysis

Medical treatment for small abdominal aortic aneurysms

Guy Rughani et al. Cochrane Database Syst Rev. .

Abstract

Background: Screening for abdominal aortic aneurysm (AAA) in selected groups is now performed in England, the USA and Sweden. Patients with aneurysms over 55 mm in diameter are generally considered for elective surgical repair. Patients with aneurysm diameters below or equal to 55 mm (termed 'small AAAs') are managed with aneurysm surveillance as there is currently insufficient evidence to recommend surgery in these cases. As more patients are screened, there will be an increasing number of small AAAs identified. There is interest in pharmaceutical interventions (for example angiotensin converting enzyme (ACE) inhibitors, antibiotics, beta-blockers, statins) which could be given to such patients to delay or reverse aneurysm expansion and reduce the need for elective surgical repair.

Objectives: To assess the effects of medical treatment on the expansion rate of small abdominal aortic aneurysms.

Search methods: The Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (May 2012) and CENTRAL (2012, Issue 5). Clinical trials databases were searched for details of ongoing or unpublished studies. The reference lists of articles retrieved by electronic searches were searched for additional citations.

Selection criteria: We selected randomised trials in which patients with small AAAs allocated to medical treatment with the intention of retarding aneurysm expansion were compared to patients allocated to a placebo treatment, alternative medical treatment, a different regimen of the same drug or imaging surveillance alone.

Data collection and analysis: Two authors independently extracted the data and assessed the risk of bias in the trials. Meta-analyses were used when heterogeneity was considered low. The two primary outcomes were the mean difference (MD) in aneurysm diameter and the odds ratio (OR) calculated to compare the number of individuals referred to AAA surgery in each group over the trial period.

Main results: Seven trials involving 1558 participants were included in this review; 457 were involved in four trials of antibiotic medication, and 1101 were involved in three trials of beta-blocker medication. Five of the studies were rated at a high risk of bias.Individually, all of the included trials reported non-significant differences in AAA expansion rates between their intervention and control groups.The two major drug groups were then analysed separately. For AAA expansion it was only possible to combine two of the antibiotic trials in a meta-analysis. This demonstrated that roxithromycin had a small but significant protective effect (MD -0.86 mm; 95% confidence interval (CI) -1.57 to -0.14). When referral to AAA surgery was compared (including all four antibiotic trials in the meta-analysis), non-significantly fewer patients were referred in the intervention groups (OR 0.96; 95% CI 0.59 to 1.57) than the control groups. When only the trials reporting actual elective surgery were included in a subgroup analysis, the result remained statistically non-significant (OR 1.17; 95% CI 0.57 to 2.42).For the beta-blocker trials, when all were combined in a meta-analysis, there was a very small, non-significant protective effect for propranolol on AAA expansion (MD -0.08 mm; 95% CI -0.25 to 0.10), and non-significantly fewer patients were referred to AAA surgery in the propranolol group (OR 0.74; 95% CI 0.52 to 1.05). Bronchospasm and shortness of breath were the main adverse effects from the beta-blockers. In one trial the adverse effects were reportedly so severe that the trial was stopped early after two years.

Authors' conclusions: There is some limited evidence that antibiotic medication may have a slight protective effect in retarding the expansion rates of small AAAs. The quality of the evidence makes it unclear whether this translates into fewer referrals to AAA surgery, owing mainly to the small sample sizes of the studies.Antibiotics were generally well tolerated with minimal adverse effects. Propranolol was poorly tolerated by patients in all of the beta-blocker trials and demonstrated only minimal and non-significant protective effects. Further research on beta-blockers for AAA needs to consider the use of drugs other than propranolol.In general, there is surprisingly little high quality evidence on medical treatment for small AAAs, especially in relation to the use of newer beta-blockers, ACE inhibitors and statins.

PubMed Disclaimer

Conflict of interest statement

None known

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Forest plot of comparison: 1 AAA expansion, outcome: 1.1 Antibiotic versus placebo.
4
4
Forest plot of comparison: 1 AAA expansion, outcome: 1.2 Propranolol versus control.
5
5
Forest plot of comparison: 2 Referral to AAA surgery, outcome: 2.1 Antibiotic versus placebo.
6
6
Forest plot of comparison: 2 Referral to AAA surgery, outcome: 2.2 Propranolol versus control.
1.1
1.1. Analysis
Comparison 1 AAA expansion, Outcome 1 Antibiotic vs Placebo.
1.2
1.2. Analysis
Comparison 1 AAA expansion, Outcome 2 Propranolol vs Control.
2.1
2.1. Analysis
Comparison 2 Referral to AAA surgery, Outcome 1 Antibiotic vs Placebo.
2.2
2.2. Analysis
Comparison 2 Referral to AAA surgery, Outcome 2 Propranolol vs Control.
3.1
3.1. Analysis
Comparison 3 Overall mortality, Outcome 1 Antibiotic vs Placebo.
3.2
3.2. Analysis
Comparison 3 Overall mortality, Outcome 2 Propranolol vs Control.
4.1
4.1. Analysis
Comparison 4 Adverse effects: all‐cause discontinuation of medication, Outcome 1 Propranolol vs Placebo.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD009536

References

References to studies included in this review

Hogh 2009 {published and unpublished data}
    1. Hogh A, Vammen S, Joensen J, Fasting H, Henneberg EW, Lindholt JS. Intermittent roxithromycin treatment for preventing small abdominal aortic aneurysms progression. Long term results from a small randomised double‐blinded clinical controlled trial. European Society for Vascular Surgery Annual Meeting. Nice, France, 4‐7th September 2008; Vol. 89.
    1. Hogh A, Vammen S, Ostergaard L, Joensen JB, Henneberg EW, Lindholt JS. Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long‐term results of a small clinical trial. Vascular and Endovascular Surgery 2009;43(5):452‐6. - PubMed
Karlsson 2009 {published data only}
    1. Karlsson L, Gnarpe J, Bergqvist D, Lindbäck J, Pärsson H. The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms‐‐a prospective randomized double‐blind trial. Journal of Vascular Surgery 2009;50(1):23‐9. - PubMed
Laupacis 2002 {published data only}
    1. The Propranolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: Results of a randomized trial. Journal of Vascular Surgery January 2002;35(1):72‐9. - PubMed
Lindholt 1999 {published data only}
    1. Lindholt JS, Henneberg EW, Juul S, Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. International Angiology 1999;18(1):52‐7. - PubMed
Mosorin 2001 {published data only}
    1. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double‐blind, placebo‐controlled pilot study. Journal of Vascular Surgery 2001;34(4):606‐10. - PubMed
Vammen 2001 {published and unpublished data}
    1. Vammen S, Lindholt JS, Ostergaard LJ, Fasting H, Henneberg EW. [Reduction of the expansion rate of small abdominal aortic aneurysms with roxithromycin. Results from a randomized controlled trial] [Hæmning af små abdominale aortaaneurismers ekspansion med roxithromycin]. Ugeskr Laeger December 2002;164(50):5916‐9. - PubMed
    1. Vammen S, Lindholt JS, Østergaard L, Fasting H, Henneberg EW. Correction: Randomised double‐blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. British Journal of Surgery 2002;89(1):120‐1. - PubMed
    1. Vammen S, Lindholt JS, Østergaard L, Fasting H, Henneberg EW. Randomized double‐blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. British Journal of Surgery 2001;88(8):1066‐72. - PubMed
Wilmink 2000 {published and unpublished data}
    1. Wilmink ABM, Hubbard CSFF, Day NE, Quick CRG. Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomised study. British Journal of Surgery 2000;87(4):499.
    1. Wilmink ABM, Hubbard CSFF, Day NE, Quick CRG. The effect of Propranolol on the expansion of Abdominal Aortic Aneurysms: a randomised study. Never published. Provided by the author.

References to studies excluded from this review

Dalman 2007 {published data only}
    1. Dalman RL. Exercise Therapy to Treat Adults With Abdominal Aortic Aneurysms. ClinicalTrials.gov [www clinicaltrials.gov] 2007 August 27.
Goessens 2006 {published data only}
    1. Goessens BM, Visseren FL, Sol BG, Man‐van Ginkel JM, Graaf Y, Smart Study Group. A randomized, controlled trial for risk factor reduction in patients with symptomatic vascular disease: the multidisciplinary Vascular Prevention by Nurses Study (VENUS). European Journal of Cardiovascular Prevention and Rehabilitation 2006;13(6):996‐1003. - PubMed
Kajimoto 2009 {published data only}
    1. Kajimoto K, Miyauchi K, Kasai T, Shimada K, Kojima Y, Shimada A, et al. Short‐term 20‐mg atorvastatin therapy reduces key inflammatory factors including c‐Jun N‐terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 2009;206(2):505‐11. - PubMed
Kothmann 2009 {published data only}
    1. Kothmann E, Batterham AM, Owen SJ, Turley AJ, Cheesman M, Parry A, et al. Effect of short‐term exercise training on aerobic fitness in patients with abdominal aortic aneurysms: a pilot study. British Journal of Anaesthesia 2009;103(4):505‐10. - PubMed
Myers 2010 {published data only}
    1. Myers JN, White JJ, Narasimhan B, Dalman RL. Effects of exercise training in patients with abdominal aortic aneurysm: preliminary results from a randomized trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2010;30(6):374‐83. - PubMed
Rahman 2011 {published data only}
    1. Rahman MN, Khan JA, Mazari FA, Mockford K, McCollum PT, Chetter IC. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery 2011;25(1):32‐8. - PubMed
Sol 2008 {published data only}
    1. Sol BG, Graaf Y, Bijl JJ, Goessens BM, Visseren FL. The role of self‐efficacy in vascular risk factor management: a randomized controlled trial. Patient Education and Counseling 2008;71(2):191‐7. - PubMed
Yonemura 2005 {published data only}
    1. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, et al. Effect of lipid‐lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. Journal of the American College of Cardiology 2005;45(5):733‐42. - PubMed
    1. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Kihara T, et al. Effect of lipid‐lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2‐year follow‐up by noninvasive MRI. European Journal of Cardiovascular Prevention and Rehabilitation 2009;16(2):222‐8. - PubMed

References to ongoing studies

ACTRN12611000931976 {published data only}
    1. Anon. The effects of Telmisartan, an angiotensin II type 1 receptor blocker, in reducing AAA growth in patients with abdominal aortic aneurysm. http://www.anzctr.org.au/ACTRN12611000931976.aspx (accessed 21 December 2011). [ACTRN12611000931976]
JPRN‐UMIN000003377 {published data only}
    1. Anon. Evaluation of the suppressing effect of Telmisarten on aneurysm development in hypertensive aortic aneurysm patients. who.int/trialsearch/Trial.aspx?TrialID=JPRN‐UMIN000003377 (accessed 28 May 2012). [JPRN‐UMIN000003377]
NCT01118520 {published data only}
    1. Anon. Evaluation of effect of angiotensin‐converting enzyme (ACE) inhibitors on small aneurysm growth rate (AARDVARK). http://clinicaltrials.gov/ct2/show/NCT01118520 (accessed 21 December 2011). [NCT01118520]
NCT01354184 {published data only}
    1. Anon. CRD007 for the treatment of abdominal aorta aneurysm (The AORTA Trial). http://clinicaltrials.gov/show/NCT01354184 (accessed 28 May 2012). [NCT01354184]
NCT01425242 {published data only}
    1. Anon. Study on anti‐inflammatory effect of anti‐hypertensive treatment in patients with small AAA's and mild hypertension (PISA). http://clinicaltrials.gov/show/NCT01425242 (accessed 28 May 2012). [NCT01425242]
NTR1345 {published data only}
    1. Anon. Doxycycline treatment for the stabilization of abdominal aortic aneurysms (AAA), a randomized placebo controlled trial. http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1345 (accessed 28 May 2012). [NTR1345]
Terrin 2011 {published data only}
    1. Terrin M. Non‐invasive treatment of abdominal aortic aneurysm clinical trial (N‐TA^3CT). http://projectreporter.nih.gov/project_info_description.cfm?aid=8043947&... (accessed 28 May 2012).

Additional references

Assar 2009
    1. Assar AN. Pharmacological therapy for patients with abdominal aortic aneurysm. Expert Review of Cardiovascular Therapy 2009;7(8):999‐1009. - PubMed
Baxter 2001
    1. Baxter BT. Regarding "Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double‐blind, placebo‐controlled pilot study" [letter; comment]. Journal of Vascular Surgery 2001;34(4):757‐8. - PubMed
Baxter 2008
    1. Baxter BT, Terrin MC, Dalman RL. Medical Management of Small Abdominal Aortic Aneurysms. Circulation 2008;117(14):1883‐9. - PMC - PubMed
Blanchard 2000
    1. Blanchard JF, Armenian HK, Friesen PP. Risk factors for abdominal aortic aneurysm: results of a case‐control study. American Journal of Epidemiology 2000;151(6):575‐83. - PubMed
Boyle 2002
    1. Boyle JR. Letter 2: Randomised double‐blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. British Journal of Surgery 2002;89(4):492. - PubMed
Bush 2006
    1. Bush RL, Johnson ML, Collins TC, Henderson WG, Khuri SF, Yu HJ, et al. Open versus endovascular abdominal aortic aneurysm aepair in VA hospitals. Journal of the American College of Surgeons 2006;202(4):577‐87. - PubMed
Cooper 2009
    1. Cooper DG, King JA, Earnshaw JJ. Role of medical intervention in slowing the growth of small abdominal aortic aneurysms. Postgraduate Medical Journal 2009;85:688‐92. - PubMed
Cosford 2007
    1. Cosford PA, Leng GC, Thomas J. Screening for abdominal aortic aneurysm. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD002945.pub2] - DOI - PubMed
Deeks 2009
    1. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Dillon 2007
    1. Dillon M, Cardwell C, Blair PH, Ellis P, Kee F, Harkin DW. Endovascular treatment for ruptured abdominal aortic aneurysm. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD005261.pub2] - DOI - PubMed
Ernst 1993
    1. Ernst CB. Abdominal aortic aneurysm. New England Journal of Medicine 1993;328(16):1167‐72. - PubMed
Filardo 2012
    1. Filardo G, Powell JT, Martinez MAM, Ballard DJ. Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD001835.pub3] - DOI - PMC - PubMed
Franks 1996
    1. Franks PJ, Edwards RJ, Greenhalgh RM, Powell JT. Risk factors for abdominal aortic aneurysm in smokers. European Journal of Vascular and Endovascular Surgery 1996;11(4):487‐92. - PubMed
Gibbs 2002
    1. Gibbs R. Letter 1: Randomised double‐blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. British Journal of Surgery 2002;89(4):491‐2. - PubMed
Greenhalgh 1998
    1. Greenhalgh RM, Forbes JF, Fowkes FG, Powel JT, Ruckley CV, Brady AR, et al. Early elective open surgical repair of small abdominal aortic aneurysms is not recommended: results of the UK Small Aneurysm Trial. Steering Committee. European Journal of Vascular and Endovascular Surgery 1998;Dec 16(6):462‐4. - PubMed
Guessous 2008
    1. Guessous I, Periard D, Lorenzetti D, Cornuz J, Ghali WA. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta‐analysis. PLoS ONE 2008;3(3):e1895. - PMC - PubMed
Higgins 2009
    1. Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Higgins 2009a
    1. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Higgins 2009b
    1. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Iribarren 2007
    1. Iribarren C, Darbinian JA, Go AS, Fireman BH, Lee CD, Grey DP. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Annals of Epidemiology 2007;17(9):669‐78. - PubMed
Johnston 1991
    1. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. Journal of Vascular Surgery 1991;13(3):452‐8. - PubMed
Lederle 2000
    1. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Archives of Internal Medicine 2000;160(10):1425‐30. - PubMed
Lederle 2002
    1. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Archer CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. New England Journal of Medicine 2002;346(19):1437‐44. - PubMed
Mazur 2004
    1. Mazur E, Niedzwiadek J, Wolski A, Siezieniewska‐Skowronska Z, Zywick W, Korolczuka A, et al. Chlamydia pneumoniae infection in abdominal aortic aneurysm (AAA) patients and its clinical impact. Polish Journal of Pathology 2004;55(4):155‐64. - PubMed
McGregor 1976
    1. McGregor JC, Pollock JG, Anton HC. The diagnosis and assessment of abdominal aortic aneurysms by ultrasonography. Annals of The Royal College of Surgeons of England 1976;58(5):388‐92. - PMC - PubMed
Miyake 2009
    1. Miyake T, Morishita R. Pharmacological treatment of abdominal aortic aneurysm. Cardiovascular Research 2009;83:436‐43. - PubMed
Newman 2001
    1. Newman AB, Arnold AM, Burke GL, O'Leary DH, Manolio TA. Cardiovascular disease and mortality in older adults with small abdominal aortic aneurysms detected by ultrasonography: the cardiovascular health study. Annals of Internal Medicine 2001;134(3):182‐90. - PubMed
Nordon 2009
    1. Nordon IM, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM. Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular 2009;17(5):253‐63. - PubMed
Paraskevas 2008
    1. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Are statins an option in the management of abdominal aortic aneurysms?. Vascular and Endovascular Surgery 2008;42(2):128‐34. - PubMed
Petersen 2002
    1. Petersen E, Boman J, Wagberg F, Angquist KA. Presence of Chlamydia pneumoniae in abdominal aortic aneurysms is not associated with increased activity of matrix metalloproteinases. European Journal of Vascular and Endovascular Surgery 2002;24(4):365‐9. - PubMed
Petrinec 1996
    1. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase‐induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. Journal of Vascular Surgery 1996;23(2):336‐46. - PubMed
Pleumeekers 1995
    1. Pleumeekers HJ, Hoes AW, Does E, Urk H, Hofman A, Jong PT, et al. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. American Journal of Epidemiology 1995;142(12):1291‐9. - PubMed
Powell 2011
    1. Powell JT, Sweeting MJ, Brown LC, Gotensparre SM, Fowkes FG, Thompson SG. Systematic review and meta‐analysis of growth rates of small abdominal aortic aneurysms. British Journal of Surgery 2011;98(5):609‐18. - PubMed
Prall 2002
    1. Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. Journal of Vascular Surgery 2002;35(5):923‐9. - PubMed
Rentschler 2006
    1. Rentschler M, Baxter BT. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture. Annals of the New York Academy of Sciences 2006;1085(1):39‐46. - PubMed
RevMan 2008 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Singh 2001
    1. Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S. Prevalence of and risk factors for abdominal aortic aneurysms in a population‐based study: The Tromso Study. American Journal of Epidemiology 2001;154(3):236‐44. - PubMed
Sterne 2009
    1. Sterne JAC, Egger M, Moher D on behalf of Cochrane Bias Methods Group. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Svensjö 2011
    1. Svensjö S, Björck M, Gürtelschmid M, Djavani Gidlund K, Hellberg A, Wanhainen A. Low prevalence of abdominal aortic aneurysm among 65‐year‐old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011;124(10):1118‐23. - PubMed
SVS 2010
    1. Society for Vascular Surgery. SAAAVE Act Background. http://www.vascularweb.org/healthpolicyandgovernmentrelations/Pages/saaa... (accessed 16 September 2011).
Thomas 2005
    1. Thomas SM, Beard JD, Ireland M, Ayers S, Vascular Society of Great Britain and Ireland, British Society of Interventional Radiology. Results from the prospective registry of endovascular treatment of abdominal aortic aneurysms (RETA): mid term results to five years. European Journal of Vascular and Endovascular Surgery 2005;29(6):563‐70. - PubMed
UKNSC 2011
    1. UK National Screening Committee. NHS Abdominal Aortic Aneurysm Screening Programme. http://www.screening.nhs.uk/aaa‐england. UKNSC, (accessed 28 January 2011).
Veith 2003
    1. Veith FJ, Ohki T, Lipsitz EC, Suggs WD, Cynamon J. Treatment of ruptured abdominal aneurysms with stent grafts: a new gold standard?. Seminars in Vascular Surgery 2003;16(2):171‐5. - PubMed
Wanhainen 2008
    1. Wanhainen A. How to define an abdominal aortic aneurysm ‐ influence on epidemiology and clinical practice. Scandinavian Journal of Surgery 2008;97(2):105‐9, discussion 109. - PubMed
Wanhainen 2011
    1. Wanhainen A, Björck M. The Swedish experience of screening for abdominal aortic aneurysm. Journal of Vascular Surgery 2011;53(4):1164‐5. - PubMed

Publication types

MeSH terms